Sirio Pharma (300791) — Financial Flexibility Index
Sirio Pharma (300791) has a Financial Flexibility Index of 0.09x as of June 2023. Free cash flow of CN¥161.25 Million (operating CF CN¥101.61 Million minus capex CN¥59.65 Million) represents 0% of total liabilities (CN¥1.85 Billion). Also explore 300791 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sirio Pharma Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Sirio Pharma across 9 annual periods. Check asset allocation strategy of Sirio Pharma to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sirio Pharma (2016–2024)
Year-by-year free cash flow to debt coverage for Sirio Pharma. For the full company profile including market capitalisation, see Sirio Pharma (300791) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.34x | CN¥979.10 Million | CN¥566.97 Million | CN¥2.84 Billion | ▲ +8.0% |
| 2023 | 0.32x | CN¥837.79 Million | CN¥386.08 Million | CN¥2.63 Billion | ▼ -36.0% |
| 2022 | 0.50x | CN¥738.55 Million | CN¥444.86 Million | CN¥1.48 Billion | ▼ -26.7% |
| 2021 | 0.68x | CN¥866.06 Million | CN¥341.38 Million | CN¥1.28 Billion | ▼ -41.6% |
| 2020 | 1.16x | CN¥542.72 Million | CN¥319.57 Million | CN¥466.95 Million | ▲ +20.7% |
| 2019 | 0.96x | CN¥398.50 Million | CN¥231.60 Million | CN¥414.01 Million | ▲ +72.9% |
| 2018 | 0.56x | CN¥422.78 Million | CN¥183.46 Million | CN¥759.53 Million | ▲ +88.3% |
| 2017 | 0.30x | CN¥209.18 Million | CN¥49.35 Million | CN¥707.58 Million | ▲ +1250.8% |
| 2016 | -0.03x | CN¥-25.61 Million | CN¥-98.26 Million | CN¥997.00 Million | — |